Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Richard Gallagher, MD, Professor of Clinical Psychiatry at New York Medical College and also a faculty member of the Columbia University Psychoanalytic Center, discusses best practices in treating…
Dr. Richard Gallagher, Professor of Clinical Psychiatry at New York Medical College and also a faculty member of the Columbia University Psychoanalytic Center, discusses best practices in treating…
Richard Gallagher, MD, Professor of Clinical Psychiatry at New York Medical College and also a faculty member of the Columbia University Psychoanalytic Center, discusses best practices in treating…
Richard Gallagher, MD, Professor of Clinical Psychiatry at New York Medical College and also a faculty member of the Columbia University Psychoanalytic Center, discusses best practices in diagnosing…
NEW YORK (Reuters Health) – In patients hospitalized for infection, continuing pre-existing statin therapy does not improve outcomes, and discontinuing the therapy does not lead to an inflammatory…
NEW YORK (Reuters Health) – Women who have undergone laparoscopic surgery for endometrioma have a reduced risk of recurrence when they take low-dose oral contraceptives, a Korean team…
NEW YORK (Reuters Health) – High-dose chemo followed by autologous stem-cell transplantation achieves good results in patients with relapsed Hodgkin’s lymphoma, and outcomes are not improved by additional…
NEW YORK (Reuters Health) – The common practice of routinely testing patients with ischemic stroke for inherited thrombophilias can do more harm than good, according to a new…
NEW YORK (Reuters Health) – About 1% of outpatient endoscopies require a subsequent visit to the emergency room for related complications, but fewer than a quarter of these…
NEW YORK (Reuters Health) – In order to minimize the risk of potential harms, erythropoiesis-stimulating agents (ESAs) in patients undergoing myelosuppressive chemotherapy should be administered at the lowest…
